Viridien
ELEM Biotech Cardiac Simulation Case Study
Pages
1
Time to read
2 mins
Publication
Language
English
Pages
1
Time to read
2 mins
Publication
Language
English
This case study details the collaboration between ELEM Biotech and Viridien HPC Cloud Solutions to enhance cardiac simulations. ELEM Biotech specializes in creating virtual humans and trials technology for the biomedical sector, enabling companies to efficiently test new drugs and devices. The integration of Viridien's high-performance cloud computing has allowed ELEM Biotech to accelerate their simulation processes by 40%, significantly improving the speed at which they can generate critical insights. The case study outlines the challenges faced by ELEM Biotech, including the need for speed, efficiency, flexibility, and customization in their simulations. It describes how the tailored HPC Cloud platforms were developed to meet ELEM Biotech's specific objectives, ensuring compliance and statistical accuracy. The results demonstrate that with the support of Viridien, ELEM Biotech is advancing the future of medicine by allowing treatments to be tested virtually, thereby expediting the research process and enhancing patient care.